Found: 10
Select item for more details and to access through your institution.
Hairy cell leukemia with isolated bone lesions.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5210, doi. 10.3390/cancers13205210
- By:
- Publication type:
- Article
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3554, doi. 10.3390/jcm9113554
- By:
- Publication type:
- Article
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2885, doi. 10.3390/cancers12102885
- By:
- Publication type:
- Article
Lymphome B de haut grade : peut-on réduire la toxicité pour les patients de pronostic favorable ?
- Published in:
- Hematologie, 2020, v. 26, n. 1, p. 13, doi. 10.1684/hma.2020.1515
- By:
- Publication type:
- Article
Pomalidomide 3rd line versus 4th line for in Early Relapsed Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e258, doi. 10.1016/j.clml.2019.09.427
- By:
- Publication type:
- Article
Weekly 20/56mg/m2 Carfilzomib, Lenalidomide and Dexamethasone until progression in Early Relapsed Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e258, doi. 10.1016/j.clml.2019.09.426
- By:
- Publication type:
- Article
Response to pneumococcal vaccination in multiple myeloma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3822, doi. 10.1002/cam4.2253
- By:
- Publication type:
- Article
Carfilzomib weekly 20/56 mg/m<sup>2</sup>, lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. E17, doi. 10.1002/ajh.25327
- By:
- Publication type:
- Article
La bendamustine en association avec la gemcitabine et la vinorelbine: traitement d'induction avant une autogreffe de cellules souches dans le lymphome de Hodgkin en rechute ou réfractaire?
- Published in:
- Hematologie, 2017, v. 23, n. 1, p. 15, doi. 10.1684/hma.2017.1219
- By:
- Publication type:
- Article